Human Immunodeficiency Virus (HIV) Fusion Inhibitors Therapeutics pipeline analysis

Human immunodeficiency virus (HIV) fusion inhibitors is the new class of antiretroviral drugs for the treatment of HIV infections. Failure of combination antiretroviral therapy in patients with HIV, has increased the risk of disease progression. This has led to the development of next generation of fusion inhibitor peptides for better treatment of HIV. Thus, fusion […]